Pacira Pharmaceuticals (PCRX) PT Raised to $67 at Northland Capital Markets
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.22 +0.96%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Northland Capital Markets analyst Tim Chiang raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $67.00 (from $61.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- Johnson Rice Downgrades Expand Energy (EXE) to Accumulate
- Harley-Davidson (HOG) PT Raised to $33 at DA Davidson Amid Progress on Back to Bricks Strategy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
